JAMA Surg:美国外科手术阿片药物使用调查

2017-04-14 MedSci MedSci原创

新的持续性阿片类药物使用可认为是一种常见的、先前被低估的外科手术神经并发症。

含阿片类药物处方常常用于长期疼痛的治疗,很少有人研究手术后持续使用阿片类药物的影响因素。研究人员近日针对外科后持续使用阿片类药物的影响因素开展工作。

研究涉及的外科手术包括小手术,例如静脉曲张切除,腹腔镜胆囊切除术,腹腔镜阑尾切除术、痔切除术,经尿道前列腺电切术、甲状旁腺切除术,以及腕管切除术等;大手术,例如腹壁切口疝修补术、结肠切除术、胃食管反流手术,减肥手术和子宫切除术等。然后,研究者评估患者持续性阿片类药物使用情况。

研究共包含患者36177人,其中小手术患者29068人(80.3%),大手术患者7109人(19.7%);平均年龄44.6岁(SD 11.9),女性23913(66.1%),白人26091(72.1%)。小手术或大手术造成的新增持续性阿片类药物使用分别为5.9%、6.5%,而非手术组为0.4%;导致新增持续性阿片类药物使用的独立因素包括吸烟(aOR 13.5;95% CI,1.21-1.49),酒精和药物滥用(aOR 1.34;95% CI,1.05-1.72),心理障碍(aOR 1.15; 95% CI,1.01-1.30),焦虑(aOR 1.25; 95% CI,1.10-1.42),疼痛疾病(背痛aOR, 1.57; 95% CI, 1.42-1.75; 颈部疼痛: aOR, 1.22; 95% CI, 1.07-1.39; 关节痛: aOR, 1.56; 95% CI, 1.40-1.73; 其他疼痛: aOR, 1.39; 95% CI, 1.26-1.54)。

外科手术后阿片类药物的使用是常见的,但大小手术对阿片类药物的使用增加没有影响,反而取决于患者的术前行为和疼痛相关障碍。这表明药物的使用不是由于手术导致的疼痛而是某些病人可预测的因素导致的。新的持续性阿片类药物使用可认为是一种常见的、先前被低估的手术神经并发症。

原文出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1719452, encodeId=40831e1945275, content=<a href='/topic/show?id=69e49e899c6' target=_blank style='color:#2F92EE;'>#阿片药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97899, encryptionId=69e49e899c6, topicName=阿片药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5832728794, createdName=zhyy99, createdTime=Mon Mar 12 04:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971529, encodeId=5dc519e15295e, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Feb 06 19:39:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343307, encodeId=a145134330e46, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Sun Apr 16 05:39:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187426, encodeId=554f18e42650, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJeleNbkWksiaqto3Vibw7iaYDyibpLMHK1vvGGiaRIsssgewmhUCCaqreYPhPjz9vyIozwdibIjYkfA87Q/0, createdBy=2b112040124, createdName=Anyway, createdTime=Fri Apr 14 18:17:53 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1719452, encodeId=40831e1945275, content=<a href='/topic/show?id=69e49e899c6' target=_blank style='color:#2F92EE;'>#阿片药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97899, encryptionId=69e49e899c6, topicName=阿片药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5832728794, createdName=zhyy99, createdTime=Mon Mar 12 04:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971529, encodeId=5dc519e15295e, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Feb 06 19:39:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343307, encodeId=a145134330e46, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Sun Apr 16 05:39:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187426, encodeId=554f18e42650, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJeleNbkWksiaqto3Vibw7iaYDyibpLMHK1vvGGiaRIsssgewmhUCCaqreYPhPjz9vyIozwdibIjYkfA87Q/0, createdBy=2b112040124, createdName=Anyway, createdTime=Fri Apr 14 18:17:53 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1719452, encodeId=40831e1945275, content=<a href='/topic/show?id=69e49e899c6' target=_blank style='color:#2F92EE;'>#阿片药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97899, encryptionId=69e49e899c6, topicName=阿片药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5832728794, createdName=zhyy99, createdTime=Mon Mar 12 04:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971529, encodeId=5dc519e15295e, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Feb 06 19:39:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343307, encodeId=a145134330e46, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Sun Apr 16 05:39:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187426, encodeId=554f18e42650, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJeleNbkWksiaqto3Vibw7iaYDyibpLMHK1vvGGiaRIsssgewmhUCCaqreYPhPjz9vyIozwdibIjYkfA87Q/0, createdBy=2b112040124, createdName=Anyway, createdTime=Fri Apr 14 18:17:53 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1719452, encodeId=40831e1945275, content=<a href='/topic/show?id=69e49e899c6' target=_blank style='color:#2F92EE;'>#阿片药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97899, encryptionId=69e49e899c6, topicName=阿片药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f5832728794, createdName=zhyy99, createdTime=Mon Mar 12 04:39:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1971529, encodeId=5dc519e15295e, content=<a href='/topic/show?id=797b8e67141' target=_blank style='color:#2F92EE;'>#药物使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87671, encryptionId=797b8e67141, topicName=药物使用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f67438, createdName=xiaogang317, createdTime=Tue Feb 06 19:39:00 CST 2018, time=2018-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343307, encodeId=a145134330e46, content=<a href='/topic/show?id=d3ea4293676' target=_blank style='color:#2F92EE;'>#外科手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42936, encryptionId=d3ea4293676, topicName=外科手术)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLGtr9t89oicQdQSIeKmOQic1weIWfibJ7H24XnT8ic9wiaUMTnXByenuwicOj8Jib42ibHXNptnuiaKthhiaVw/132, createdBy=ac342500190, createdName=ms7524819409032184, createdTime=Sun Apr 16 05:39:00 CST 2017, time=2017-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=187426, encodeId=554f18e42650, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEJeleNbkWksiaqto3Vibw7iaYDyibpLMHK1vvGGiaRIsssgewmhUCCaqreYPhPjz9vyIozwdibIjYkfA87Q/0, createdBy=2b112040124, createdName=Anyway, createdTime=Fri Apr 14 18:17:53 CST 2017, time=2017-04-14, status=1, ipAttribution=)]
    2017-04-14 Anyway

    学习了

    0

相关资讯

Nat Commun:无副作用的止痛

本期Nature Communications上发表的一项研究识别出一个负责介导吗啡的止痛效应、但不会产生有害副作用的一个特定钾通道。这些发现也许可帮助开发副作用小的止痛药。 吗啡在治疗一些形式的急性和慢性疼痛方面非常有效,但其使用经常受到相关副作用的限制。主要副作用包括便秘、呼吸抑制和上瘾。吗啡通过在吗啡受体上发挥作用来施加其影响,已知对控制传输疼痛的神经元的可激发性的钾通道的活性有间接影响。

Sci Rep:孕妇千万不要再随意吃布洛芬了!

布洛芬是孕妇最常用的药物之一,有报告称其使用量高达28%。但是,目前仍然不知道布洛芬是否和其他镇痛药如乙酰氨基酚和阿司匹林一样能够干扰内分泌。近期,一项发表在杂志Sci Rep上的文章对这一问题进行了研究。研究者们使用体外培养和异种移植系统将人类胎儿睾丸组织(7-17孕周(GW))暴露于布洛芬中。布洛芬在8-9GW胎儿睾丸培养期间抑制睾酮和Leydig细胞激素INSL3,同时减少类固醇生成酶CYP

Neuropharmacology:研究者发现更安全不上瘾的止痛药!

杜兰大学和路易斯安那东南部的退伍军人医疗系统的研究员发现了一种新的止痛药,具有吗啡相似的止痛效果,但不会上瘾,副作用更少!该基于内啡肽的药物与吗啡有相同的镇痛受体。以鸦片为基础的药物是治疗严重和慢性疼痛的主要方法,但它们可以很容易上瘾。在美国药物滥用导致每年数***死亡。此外药物滥用会导致运动障碍和潜在致命的呼吸抑制。随着时间的推移耐受性的增加,滥用和过量使用药物的风险也在增加。该项研究中,新的内吗

JAMA:急性腰痛患者并不建议在萘普生基础上增加其它止痛药物

意义  在每年到美国急诊科(EDs)就诊的患者中,有超过250万是因为腰痛(LBP)。这些患者通常接受非类固醇类抗炎药、对乙酰氨基酚、阿片类药物或骨骼肌松弛药的治疗,且常常是联合治疗。 目的  将因急性腰痛到ED就诊的患者随机分为3组,分别给予1个10天疗程的⑴萘普生+安慰剂、⑵萘普生+环苯扎林或⑶萘普生+羟考酮/对乙酰氨基酚治疗,比较这些患者在急诊科就诊后1周和3个月时

PAIN:阿片类止痛药物剂量增加导致抑郁症

最近的研究表明,长时间持续使用阿片类药物(与最大吗啡当量剂量(MED)无关)与新发抑郁症(NOD)的风险增加相关。相反,也有一些研究显示,不考虑治疗持续时间,发现MED剂量可以增加抑郁症状的概率。为了确定MED增加的速率是否与NOD相关,一项研究关于退伍军人健康管理数据(2000-2012)的回顾性队列分析近期发表在PAIN杂志上。此项研究入组人群为近期慢性(> 90天)阿片样物质使用者,年

CSMO 2014:老年癌痛的药物治疗

在7月4日的第八届中国肿瘤内科大会会上,北京军区总医院的李小梅教授了介绍了老年癌痛的药物治疗情况。老年患者是姑息治疗、终末期患者照护的主体,更是癌痛治疗的主体。长期以来,对老年癌痛评估不充分的现象普遍存在,其原因复杂多样:临床医生常因过度担心止痛药物的副作用或缺乏对老年患者止痛药物药代动力学变化特点的了解而不愿意处方止痛药、或处方剂量低于实际需要量;癌痛评估、治疗不足无疑对患者生活质量的产生诸多负